NPs Basic Information

Name
Pyrogallol
Molecular Formula C6H6O3
IUPAC Name*
benzene-1,2,3-triol
SMILES
C1=CC(=C(C(=C1)O)O)O
InChI
InChI=1S/C6H6O3/c7-4-2-1-3-5(8)6(4)9/h1-3,7-9H
InChIKey
WQGWDDDVZFFDIG-UHFFFAOYSA-N
Synonyms
pyrogallol; benzene-1,2,3-triol; 87-66-1; 1,2,3-trihydroxybenzene; pyrogallic acid; 1,2,3-benzenetriol; fourrine PG; Fouramine Brown AP; fourrine 85; Pyro; Piral; C.I. Oxidation Base 32; Benzenetriol; fouramine base ap; C.I. 76515; 1,2,3-Trihydroxybenzen; Benzene, 1,2,3-trihydroxy-; NSC 5035; 2,3-Dihydroxyphenol; 1,2,3-Trihydroxybenzen [Czech]; 1,2,3-TRIHYDROXY-BENZENE; NSC-5035; 01Y4A2QXY0; CHEMBL307145; 35296-77-6; CHEBI:16164; Benzene-1,2,3-triol (Pyrogallol); MFCD00002192; NCGC00091507-01; 1, 2, 3-Benzenetriol; DSSTox_CID_5983; DSSTox_RID_77980; DSSTox_GSID_25983; 30813-84-4; 1,2,3-Trihydroxybenzen (CZECH); CI Oxidation Base 32; CAS-87-66-1; Pyrogallol [NF]; PYG; CCRIS 1940; HSDB 794; PYROGALLOL, ACS; EINECS 201-762-9; BRN 0907431; UNII-01Y4A2QXY0; CI 76515; Pyrogallol;; trihydroxybenzene; AI3-00709; Pyrogallol-[d6]; 1,3-Benzenetriol; Pyrogallol, 98%; PYROP; Pyrogallol ACS grade; 1,3-Trihydroxybenzen; 1216684-97-7; Pyrogallic Acid,(S); 1,3-Trihydroxybenzene; benzene-1,2-3-triol; PYROGALLOL [MI]; Pyrogallol, ACS reagent; PYROGALLOL [HSDB]; PYROGALLOL [INCI]; Benzene,2,3-trihydroxy-; WLN: QR BQ CQ; PYROGALLOL [VANDF]; PYROGALLOL [MART.]; SCHEMBL3532; PYROGALLOL [WHO-DD]; C.I. Oxidation Base 32; 4-06-00-07327 (Beilstein Handbook Reference); MLS001066376; Pyrogallol, analytical standard; 1,2,3-Trihydroxybenzene, XIV; DTXSID6025983; Pyrogallol, >=98% (HPLC); Pyrogallol, p.a., ACS reagent; NSC5035; ZINC330141; BCP15871; HY-N1579; Pyrogallol, ACS reagent, >=99%; STR08708; Tox21_111143; Tox21_202373; BBL011607; BDBM50031472; Pyrogallol, Vetec(TM) reagent grade; s3885; STL163335; AKOS000120163; AM10660; CCG-266100; CS-W019928; 1,2,3-Benzenetriol (ACD/Name 4.0); NCGC00091507-02; NCGC00091507-03; NCGC00259922-01; Pyrogallol, purum, >=98.0% (HPLC); AC-11384; BP-12538; DA-40956; GMN; Pyrogallol, SAJ first grade, >=98.0%; SMR000471842; Pyrogallol, JIS special grade, >=99.0%; FT-0606230; P0570; EN300-18055; C01108; AB-131/40221933; Q388692; W-104009; Z57127553; 2,3-Dihydroxyphenol; Benzene-1,2,3-triol; NSC 5035; F0001-2163
CAS 87-66-1
PubChem CID 1057
ChEMBL ID CHEMBL307145
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Benzenoids
      • Class: Phenols
        • Subclass: Benzenetriols and derivat
          • Direct Parent: 5-unsubstituted pyrrogall

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 126.11 ALogp: 0.5
HBD: 3 HBA: 3
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 60.7 Aromatic Rings: 1
Heavy Atoms: 9 QED Weighted: 0.458

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.895 MDCK Permeability: 0.00001400
Pgp-inhibitor: 0.001 Pgp-substrate: 0.002
Human Intestinal Absorption (HIA): 0.046 20% Bioavailability (F20%): 0.982
30% Bioavailability (F30%): 0.959

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.043 Plasma Protein Binding (PPB): 71.10%
Volume Distribution (VD): 0.307 Fu: 21.64%

ADMET: Metabolism

CYP1A2-inhibitor: 0.102 CYP1A2-substrate: 0.305
CYP2C19-inhibitor: 0.054 CYP2C19-substrate: 0.061
CYP2C9-inhibitor: 0.1 CYP2C9-substrate: 0.627
CYP2D6-inhibitor: 0.08 CYP2D6-substrate: 0.374
CYP3A4-inhibitor: 0.04 CYP3A4-substrate: 0.133

ADMET: Excretion

Clearance (CL): 19.339 Half-life (T1/2): 0.935

ADMET: Toxicity

hERG Blockers: 0.01 Human Hepatotoxicity (H-HT): 0.051
Drug-inuced Liver Injury (DILI): 0.06 AMES Toxicity: 0.7
Rat Oral Acute Toxicity: 0.559 Maximum Recommended Daily Dose: 0.028
Skin Sensitization: 0.948 Carcinogencity: 0.638
Eye Corrosion: 0.974 Eye Irritation: 0.975
Respiratory Toxicity: 0.84
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000404 0.600 D07MOX 0.366
ENC000021 0.533 D0T7OW 0.350
ENC000690 0.514 D07HBX 0.342
ENC002350 0.452 D0V9EN 0.341
ENC000683 0.450 D04PHC 0.341
ENC001513 0.439 D07EXH 0.333
ENC000329 0.412 D08HVR 0.326
ENC002237 0.409 D03UOT 0.314
ENC000390 0.395 D0I3RO 0.313
ENC000002 0.395 D0BA6T 0.313
*Note: the compound similarity was calculated by RDKIT.